Pamela Kunz, MD, Associate Professor (Medical Oncology), Director of the Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer Center, and Chief of GI Medical Oncology, was named a Fellow of the American Society of Clinical Oncology (FASCO). The FASCO distinction honors members of the American Society of Clinical Oncology (ASCO) for their extraordinary volunteer service, commitment, and dedication to the organization that benefits not only the field of oncology as a whole, but patients as well. Dr. Kunz was one of 10 recipients nationwide to earn the FASCO designation this year.
ASCO represents nearly 50,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. It is supported by its affiliate organization, the Conquer Cancer Foundation. Dr. Kunz is an international leader in the treatment and clinical research of patients with GI malignancies and neuroendocrine tumors (NETs). In addition to her focus on NETs, she is a leading voice for promoting diversity, equity and inclusion in medicine. She served as the Vice Chief of DEI for the Section of Medical Oncology at Yale School of Medicine and, in 2021, she was awarded ‘Woman Oncologist of the Year’ by Women Leaders in Oncology for her work in promoting gender equity.
The 2024 Fellows of ASCO will be recognized on Saturday, June 1st at the ASCO annual meeting held in Chicago, Illinois. Dr. Kunz joins nine Yale Cancer Center members who have earned the FASCO distinction: Anees Chagpar, MD, MBA, MPH, FACS, FRCS(C); Veronica Chiang, MD, FAANS; Vincent DeVita, Jr., MD; Roy S. Herbst, MD, PhD; Jill Lacy, MD; Eric Winer, MD; Patricia LoRusso, DO; Veda Giri, MD, and Lajos Pusztai, MD, DPhil.